To underline the importance of charting gaps in predicting small-cap share prices, Zak Mir looks at some of the best examples over the past year: Arrow, Baron, Empire, Lexington, Manx,
To underline the importance of charting gaps in predicting small-cap share prices, Zak Mir looks at some of the best examples over the past year: Arrow, Baron, Empire, Lexington, Manx,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Angus, Avacta, Carclo,
East Star Resources (EST), the Kazakhstan-focused gold, rare earths and copper explorer, is pleased to present its interim results for the six-month period ended 31 May 2022.
As Russia tightens its grip on Europe’s gas supplies, the UK is set to experience record-breaking energy prices this winter. This will only add to Britain’s current cost-of-living crisis.
Russia’s gas cut could fracture the unity of Europe’s Union this winter, as tight budgets and supply issues limit the bloc’s ability to deal with an unexpected, severe energy shortage.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  FTSE 100, Bitcoin, Active, Dotdigital, Kistos,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  FTSE 100, Bitcoin, Aston Martin, Bens,
RiverFort Global Opportunities (RGO), the investment company listed on AIM, announced its audited final results for the year ended 31 December 2021 RGO recorded a net profit generated of £1,040,012,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Kistos, Northbridge, Okyo, Powerhouse, Rambler, Southern,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  Arrow, AfriTin, Caspian, ECR, Hercules, i3
ANGLE (AGL), a liquid biopsy company, said that a leading cancer research institute, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, has published results of work undertaken in advanced non-small